Search Results for: IFT80

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel FGFR4 fibroblast growth factor receptor 4
  • PI3K Cascade
  • PIP3 activates AKT signaling
  • betaKlotho-mediated ligand binding
  • FGFR4 mutant receptor activation
  • FGFR4 ligand binding and activation
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Phospholipase C-mediated cascade; FGFR4
  • FRS-mediated FGFR4 signaling
  • SHC-mediated cascade:FGFR4
  • PI-3K cascade:FGFR4
  • Negative regulation of FGFR4 signaling
  • Signaling by FGFR4 in disease
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Heparin
  • Ponatinib
  • Lenvatinib
  • Erdafitinib
  • Pemigatinib
Novel NMD3 NMD3 ribosome export adaptor
Novel OTOL1 otolin 1
Novel SLITRK3 SLIT and NTRK like family member 3
  • Receptor-type tyrosine-protein phosphatases
Novel ZBBX zinc finger B-box domain containing
PLXNA2 plexin A2
  • Sema3A PAK dependent Axon repulsion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • CRMPs in Sema3A signaling
  • CRMPs in Sema3A signaling
  • Other semaphorin interactions
UBXN10 UBX domain protein 10

Page 1 out of 1 pages